KemPharm Company Profile (NASDAQ:KMPH)

About KemPharm

KemPharm logoKemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is combined with acetaminophen (APAP). The Company is developing KP201/APAP as an immediate release (IR), a product candidate for the short-term, or no longer than 14 days for the management of acute pain. The Company has designed KP201/APAP with abuse-deterrent properties to address the epidemic of opioid abuse in the United States. The Company also focuses on developing the pipeline of additional prodrug product candidates that targets pain and attention deficit hyperactivity disorder (ADHD). The Company's products include KP201/IR (APAP-free), KP511/ER, KP415, KP606/IR and KP746.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: KMPH
  • CUSIP:
Key Metrics:
  • Previous Close: $4.49
  • 50 Day Moving Average: $4.69
  • 200 Day Moving Average: $8.09
  • 52-Week Range: $3.52 - $21.30
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.07
  • P/E Growth: 0.00
  • Market Cap: $65.76M
  • Outstanding Shares: 14,646,000
  • Beta: -1.79
Profitability:
  • Return on Assets: -14.52%
Debt:
  • Debt-to-Equity Ratio: 273.88%
  • Current Ratio: 11.44%
  • Quick Ratio: 11.44%
Additional Links:
Companies Related to KemPharm:

Analyst Ratings

Consensus Ratings for KemPharm (NASDAQ:KMPH) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.67 (338.01% upside)

Analysts' Ratings History for KemPharm (NASDAQ:KMPH)
Show:
DateFirmActionRatingPrice TargetDetails
8/10/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/14/2016Oppenheimer Holdings Inc.Reiterated RatingBuy$11.00View Rating Details
5/8/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details
8/15/2015Cowen and CompanyReiterated RatingBuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for KemPharm (NASDAQ:KMPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/11/2016        
8/10/2016Q2($0.94)($0.58)ViewListenView Earnings Details
5/12/2016Q1($0.46)($0.20)ViewListenView Earnings Details
3/10/2016Q4($0.50)($0.64)ViewListenView Earnings Details
11/12/2015Q315($0.42)($0.68)ViewListenView Earnings Details
8/13/2015Q215($0.47)($2.45)ViewListenView Earnings Details
5/27/2015Q1($0.49)($2.50)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for KemPharm (NASDAQ:KMPH)
Current Year EPS Consensus Estimate: $-1.49 EPS
Next Year EPS Consensus Estimate: $-2.17 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20161($0.59)($0.59)($0.59)
Q3 20161($0.70)($0.70)($0.70)
Q4 20161($0.72)($0.72)($0.72)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for KemPharm (NASDAQ:KMPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for KemPharm (NASDAQ:KMPH)
Insider Ownership Percentage: 22.80%
Institutional Ownership Percentage: 42.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2016Daniel L CohenEVPBuy10,000$4.75$47,500.00View SEC Filing  
8/17/2016Travis C MickleCEOBuy5,000$4.95$24,750.00View SEC Filing  
3/29/2016Travis C MickleCEOBuy2,450$14.57$35,696.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for KemPharm (NASDAQ:KMPH)
DateHeadline
News IconKemPharm, Inc. (KMPH) Latest Broker Coverage - NewsDen (NASDAQ:KMPH)
newsden.net - September 29 at 10:53 AM
News IconStocks within Analyst Limelight: Bonanza Creek Energy, Inc. (NYSE:BCEI) , KemPharm, Inc. (NASDAQ:KMPH) - Wall Street Times (press release) (NASDAQ:KMPH)
www.wallstreetnews24.com - September 29 at 10:53 AM
News IconSizzling Stock Alert: Churchill Downs, Incorporated (NASDAQ:CHDN) , KemPharm, Inc. (NASDAQ:KMPH) - Wall Street Times (press release) (NASDAQ:KMPH)
www.wallstreetnews24.com - September 22 at 9:02 AM
News IconStock Perspective: KemPharm Inc (NASDAQ:KMPH) Company Earnings Watch - Frisco Fastball (NASDAQ:KMPH)
friscofastball.com - September 22 at 9:02 AM
streetinsider.com logoKemPharm (KMPH) Announces Filing of KP415 IND as ADHD Treatment (NASDAQ:KMPH)
www.streetinsider.com - September 21 at 9:59 AM
biz.yahoo.com logoKEMPHARM, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:KMPH)
biz.yahoo.com - September 21 at 9:59 AM
4-traders.com logoKemPharm : Files IND for KP415 for the Treatment of ADHD, An Investigational Prodrug of D-Threo-Methylphenidate (NASDAQ:KMPH)
www.4-traders.com - September 20 at 10:58 AM
publicnow.com logoKemPharm Files IND for KP415 for the Treatment of ADHD, An Investigational Prodrug of D-Threo-Methylphenidate (NASDAQ:KMPH)
www.publicnow.com - September 19 at 10:22 AM
globenewswire.com logoKemPharm, Inc. Provides Corporate and Clinical Update - GlobeNewswire (press release) (NASDAQ:KMPH)
globenewswire.com - September 17 at 5:32 PM
4-traders.com logoKemPharm : Provides Corporate and Clinical Update (NASDAQ:KMPH)
www.4-traders.com - September 16 at 12:29 PM
News IconKemPharm, Inc. Provides Corporate and Clinical Update - EconoTimes (NASDAQ:KMPH)
www.econotimes.com - September 15 at 3:44 PM
streetinsider.com logoKemPharm (KMPH) Announces key Corporate and Clinical Updates - StreetInsider.com (NASDAQ:KMPH)
www.streetinsider.com - September 15 at 9:06 AM
publicnow.com logoKemPharm, Inc. Provides Corporate and Clinical Update (NASDAQ:KMPH)
www.publicnow.com - September 15 at 9:06 AM
News IconSell-side Consensus Sees KemPharm Inc (NASDAQ:KMPH) Going Where Near-Term? - Frisco Fastball (NASDAQ:KMPH)
friscofastball.com - September 9 at 10:34 AM
News IconThe Sell-side Consensus is in on KemPharm Inc (NASDAQ:KMPH); Earnings & Target Updates - National Daily Press (NASDAQ:KMPH)
www.nationaldailypress.com - September 9 at 10:34 AM
globenewswire.com logoKemPharm to Present Data at PAINWeek 2016 - GlobeNewswire (press release) (NASDAQ:KMPH)
www.globenewswire.com - September 8 at 5:43 PM
finance.yahoo.com logoKemPharm to Present Data at PAINWeek 2016 - Yahoo Finance (NASDAQ:KMPH)
finance.yahoo.com - September 8 at 9:43 AM
finance.yahoo.com logo7:32 am KemPharm announces data from 2 studies involving KP201 ahead of their presentation at PAINWeek 2016 (NASDAQ:KMPH)
finance.yahoo.com - September 8 at 9:43 AM
publicnow.com logoKemPharm to Present Data at PAINWeek 2016 (NASDAQ:KMPH)
www.publicnow.com - September 8 at 9:43 AM
News IconCrowd Perspectives & Analyst Views on KemPharm Inc (NASDAQ:KMPH)? - Post News (NASDAQ:KMPH)
www.kentuckypostnews.com - August 24 at 8:56 AM
finance.yahoo.com logoKEMPHARM, INC Financials (NASDAQ:KMPH)
finance.yahoo.com - August 19 at 5:49 PM
finance.yahoo.com logoEdited Transcript of KMPH earnings conference call or presentation 10-Aug-16 12:30pm GMT (NASDAQ:KMPH)
finance.yahoo.com - August 19 at 5:49 PM
News IconStock's Financial Statistics- KemPharm, Inc.'s (KMPH) - Hot Stocks Point (NASDAQ:KMPH)
www.hotstockspoint.com - August 18 at 5:52 PM
News IconKemPharm, Inc.'s (KMPH): Stock in the Spotlight - Hot Stocks Point (NASDAQ:KMPH)
www.hotstockspoint.com - August 18 at 5:52 PM
News IconWhat's KemPharm Inc. (NASDAQ: KMPH) Near-Term Challenge? - Scibility Media (NASDAQ:KMPH)
scibilitymedia.com - August 18 at 5:52 PM
zacks.com logoKemPharm (KMPH) Looks Good: Stock Adds 9% in Session (NASDAQ:KMPH)
www.zacks.com - August 18 at 8:53 AM
News IconStock Moving Up in Session: KemPharm, Inc. (NASDAQ:KMPH) - Post News (NASDAQ:KMPH)
www.kentuckypostnews.com - August 16 at 5:58 PM
sg.finance.yahoo.com logoKemPharma posts 2Q profit (NASDAQ:KMPH)
sg.finance.yahoo.com - August 10 at 8:49 AM
publicnow.com logoKemPharm, Inc. Reports Second Quarter 2016 Results (NASDAQ:KMPH)
www.publicnow.com - August 10 at 8:49 AM
biz.yahoo.com logoKemPharm Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:KMPH)
biz.yahoo.com - August 10 at 8:49 AM
publicnow.com logoKemPharm, Inc. to Report Second Quarter 2016 Results (NASDAQ:KMPH)
www.publicnow.com - August 2 at 6:04 PM
publicnow.com logoKemPharm to Present at Canaccord Genuity 36th Annual Growth Conference (NASDAQ:KMPH)
www.publicnow.com - July 28 at 8:28 AM
kcregister.com logoKemPharm, Inc. (NASDAQ:KMPH) soared 6.38%: Flexible Solutions International Inc. (NYSEMKT:FSI), Tractor Supply ... - KC Register (NASDAQ:KMPH)
www.kcregister.com - July 23 at 9:49 AM
News IconKemPharm Inc (NASDAQ:KMPH): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:KMPH)
www.engelwooddaily.com - July 23 at 9:49 AM
News IconHow Analysts Feel About KemPharm Inc After Today's Huge Increase? - Press Telegraph (NASDAQ:KMPH)
presstelegraph.com - July 21 at 6:03 PM
News IconChecking in on Stock Volatility for: KemPharm, Inc. (NASDAQ:KMPH) - Engelwood Daily (NASDAQ:KMPH)
www.engelwooddaily.com - July 21 at 6:03 PM
News IconEquity Roundup: Stock Performance Focus on KemPharm Inc (NASDAQ:KMPH) - Press Telegraph (NASDAQ:KMPH)
presstelegraph.com - July 21 at 6:03 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for KemPharm Inc (NASDAQ:KMPH) - TGP (NASDAQ:KMPH)
telanaganapress.com - July 20 at 3:58 PM
News IconHow Many KemPharm Inc (NASDAQ:KMPH)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:KMPH)
www.consumereagle.com - July 17 at 10:13 AM
News IconShares Experiencing a Downtrend: KemPharm, Inc. (NASDAQ:KMPH) - TGP (NASDAQ:KMPH)
telanaganapress.com - July 16 at 5:34 PM
News IconKemPharm Inc (NASDAQ:KMPH) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:KMPH)
www.engelwooddaily.com - July 15 at 9:54 AM
News IconAnalyst Target and Average Rating Watch: KemPharm Inc (NASDAQ:KMPH) - Press Telegraph (NASDAQ:KMPH)
presstelegraph.com - July 15 at 9:54 AM
streetinsider.com logoKemPharm (KMPH) Completes Key Meetings with FDA forKP201/IR and KP415; Sees Submitting INDs in H216 - StreetInsider.com (NASDAQ:KMPH)
www.streetinsider.com - July 14 at 6:04 PM
News IconTrading Performance and Target Watch for KemPharm Inc (NASDAQ:KMPH) - Press Telegraph (NASDAQ:KMPH)
presstelegraph.com - July 14 at 6:04 PM
publicnow.com logoKemPharm Completes Key Regulatory Meetings with FDA for KP201/IR and KP415 (NASDAQ:KMPH)
www.publicnow.com - July 14 at 4:48 PM
News IconKemPharm Inc (NASDAQ:KMPH) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:KMPH)
telanaganapress.com - July 13 at 6:14 PM
ftsenews.co.uk logoKemPharm, Inc. (KMPH) Updated Price Targets - FTSE News (NASDAQ:KMPH)
www.ftsenews.co.uk - July 11 at 5:55 PM
News IconStock Volatility Focus for: KemPharm, Inc. (NASDAQ:KMPH) - Engelwood Daily (NASDAQ:KMPH)
www.engelwooddaily.com - July 11 at 5:55 PM
News IconShares Dipping Lower in Session: KemPharm, Inc. (NASDAQ:KMPH) - Telanagana Press (NASDAQ:KMPH)
telanaganapress.com - July 11 at 5:55 PM
News IconWere Analysts Bearish KemPharm Inc (NASDAQ:KMPH) This Week? - Engelwood Daily (NASDAQ:KMPH)
www.engelwooddaily.com - July 9 at 9:15 AM

Social

KemPharm (NASDAQ:KMPH) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff